Celemics, Inc. (KOSDAQ: 331920)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,310.00
-170.00 (-4.89%)
Dec 19, 2024, 1:55 PM KST

Celemics Company Description

Celemics, Inc. designs, manufactures, and distributes sequencing kits in South Korea.

The company offers whole exome sequencing panels; NGS target enrichment panels; customized and ready-to-use enrichment panels; and modular accessories, including library preparation kits, double standard Cdna synthesis, hybridization enhancer, celan-up and streptavidin beads, CeleNM beads, and polymerase.

It also provides celemics analysis, whole exome sequencing, customized NGS panels, sequencing, bioinformatics, biopharma, and custom NGS assay development services.

Its products are used in oncology, liquid biopsy, biopharma solutions, inherited diseases, pharmacogenomics, virus research, agrigenomics, RNA sequencing, epigenetics, metagenomic sequencing, antibody discovery, and bioinformatics applications.

The company was founded in 2010 and is headquartered in Seoul, South Korea.

Celemics, Inc.
Country South Korea
Founded 2010
Industry Surgical and Medical Instruments and Apparatus
Employees 42

Contact Details

Address:
Building A
Seoul, 08506
South Korea
Phone 82 2 6746 8067
Website celemics.com

Stock Details

Ticker Symbol 331920
Exchange KOSDAQ
Fiscal Year January - December
Reporting Currency KRW
SIC Code 3841